SOLUGEN INC

Lobbying for SOLUGEN INC · Industrial Biomanufacturing

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Expenses

$130,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Texas

Official filing document

Government bodies contacted 4

Defense, Dept of (DOD)
Executive Office of the President (EOP)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Defense

Support the use of bio-based chemicals in the Department of Defense, generally. Department of Defense Appropriations Act for Fiscal Year 2027. National Defense Authorization Act for Fiscal Year 2027.

Environment/Superfund

Educate policymakers about Solugen's technology to produce bio-based chemicals, generally.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.